Applications
-
IHC-P
-
FC
-
ELISA
REACTIVITY
-
Human
SPECIFICATIONS
Product Type
Mouse monoclonal primary
Product Name
xanthine dehydrogenase Monoclonal Antibody (EM1701-56)
Immunogen
Peptide
Host
Mouse
Positive Control
Human liver tissue, human kidney tissue, LOVO.
Conjugation
Unconjugated
Clonality
Monoclonal
Clone Number
1C8
PROPERTIES
Form
Liquid
Storage Condition
Store at +4C after thawing. Aliquot store at -20C. Avoid repeated freeze / thaw cycles.
Storage Buffer
1*PBS (pH7.4), 0.2% BSA, 50% Glycerol. Preservative: 0.05% Sodium Azide.
Concentration
2 ug/ul
PURIFICATION
Protein G purified.
MOLECULAR WEIGHT
146 kDa
Isotype
IgG1
APPLICATION DILUTION
-
IHC-P
-
1:50-1:200
-
FC
-
1:50-1:100
-
ELISA
-
1:5,000-1:10,000
TARGET
UNIPROT #
PROTEIN NAME
xanthine dehydrogenase
SYNONYMS
Xanthine dehydrogenase antibody; Xanthine dehydrogenase/oxidase antibody; Xanthine oxidase antibody; Xanthine oxidoreductase antibody; XD antibody; XDH antibody; XDH_HUMAN antibody; xdha antibody; XO antibody; xor antibody
SEQUENCE SIMILARITIES
Belongs to the xanthine dehydrogenase family.
TISSUE SPECIFICITY
Detected in milk (at protein level).
POST-TRANSLATIONAL MODIFICATION
Subject to partial proteolysis; this alters the enzyme from the dehydrogenase form (D) to the oxidase form (O).; Contains sulfhydryl groups that are easily oxidized (in vitro); this alters the enzyme from the dehydrogenase form (D) to the oxidase form (O).
SUBCELLULAR LOCATION
Cytoplasm. Secreted. Peroxisome.
FUNCTION
The process of metabolizing purines to a common molecule known as xanthine is an essential process for the proper shuttling of uric acid. Xanthine oxidase is a flavoprotein enzyme that coordinates molybdenum and utilizes NAD+ as an electron acceptor to catalyze the oxidation of hypoxanthine to xanthine and then to uric acid. The predominant form of this enzyme is xanthine dehydrogenase, which is a homodimer that can be converted to xanthine oxidase by sulfhydryl oxidation or proteolytic modification. Xanthine oxidase is present in species ranging from bacteria to human and is ubiquitously expressed in mammalian tissues. In the oxidase form, this enzyme is coupled to the generation of free radicals. Individuals showing marked elevation of serum xanthine oxidase is suggestive of chronic liver disease and cholestasis, which is a condition defined by hepatic obstruction. Hepatic obstruction causes bile salts, the bile pigment bilirubin, and fats to accumulate in the blood stream instead of being eliminated normally. The clinical consequences of defects in xanthine oxidase range from mild to severe and even contribute to fatal disorders.